Chronic leukemias CML CLL MDS.

Slides:



Advertisements
Similar presentations
TA OGUNLESI (FWACP)1 CHILDHOOD LEUKAEMIA. TA OGUNLESI (FWACP)2 LEUKAEMIA Heterogenous group of malignant disorders Characterised by uncontrolled clonal.
Advertisements

NEOPLASTIC DISORDERS OF THE BONE MARROW
Introduction To Haematological Malignancies
Myelodysplastic Syndrome
LEUKEMIA.
LEUKEMIA—HEMATOLOGY {S1}
Myelodysplastic Syndrome
1 Chronic Leukemia Dr.Huad alkarim.. 2 What Are the Types of Chronic Leukemia?
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
LEUKEMIAS Dr Mehboob Khan Pathologist
WHO CLASSIFICATION OF MYELOID NEOPLASMS 2000  Chronic myeloproliferative disorders (CMPD)  Myelodysplastic / myeloproliferative diseases (MDS/MPD) 
Chronic lymphocytic leukemia (1)
Chapter 17 Chronic Leukemias.
Chronic Leukemia Dr. Rania Alhady Chronic Lymphocytic leukemia (CLL):
Chronic leukemias. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
CHRONIC MYELOID LEUKAEMIA Dr Rosline Hassan Department of Haematology School of Medical Sciences Universiti Sains Malaysia.
Tabuk University Faculty of Applied Medical Sciences
Acute Myeloid Leukemias (AML)
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
3 rd Year – Level 5 – AY Dr. Walid ZAMMITI Msc, PhD MLT Faculty of Applied Medical Sciences Department Of Medical Lab. Technology HEMATOLOGY.
HAEMATOLOGY PRESENTATION TZE YENG YEOH MBChB II (2003)
Myeloprolifrative disorders -Chronic Myelogenouse Leukemia - Primary Poly Cythemia ( vira ) - Essential Thrombocythemia - Myelofibrose Myeloid Methaplasia.
C HRONIC LEUKEMIAS. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
Chronic Leukemias. CMLCML CLLCLL CML A clonal disease results from an acquired genetic change in a pluri-potential hemopoietic stem cell within the BM.
Myeloproliferative Disorders (MPDs)
Myelodysplastic Syndrome (MDS)
The myelodysplastic syndromes (MDS) Aquired Clonal disease of BM. comprise a heterogeneous group of malignant stem cell disorders characterized by : 1.
MLAB HEMATOLOGY KERI BROPHY-MARTINEZ Myelodysplastic Syndromes.
4th Year Medical Student KAU
Hematology and Hematologic Malignancies
Chronic leukemia 1. Chronic Lymphocytic leukemia (CLL) * Definition: Chronic neoplastic disorder characterized by accumulation of small mature-looking.
Chronic myeloid leukaemia (CML)
CHRONIC LEUKEMIA Dr. Hayam Hebah Associate professor of Internal Medicine AL Maarefa College.
Heterogeneous group of hematopoietic neoplasms Uncontrolled proliferation and decreased apoptotic activity with variable degrees of differentiation Composed.
Leukaemias. Leukaemias: Malignant Disease of WBC Forming tissue or other hemopoietic elements: Lymphoblastic (ALL) Lymphoblastic (ALL)Acute Myeloid (AML)
..  Neoplastic proliferation of small mature appearing  lymphocytes and account 25% of leukemia  It is rare before 40 years of age, the median age.
MLAB 1415: Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
Acute Leukemia Kristine Krafts, M.D..
Myeloproliferative disorder Clonal evolution Clonal evolution & stepwise progression to fibrosis, marrow failure or acute blast phase.
Chronic leukemias أ. م. د. محمد شنين علي العبادي معاون عميد كلية الطب / جامعة كربلاء ورئيس فرع الامراض والطب العدلي M. B. Ch. B. & F. I. C. P.(Hematopathology)
LEUKEMIA Dr. Omar Alshaer. Acute Leukemia.
AML Clinical Presentation. Clinical Presentation: Symptoms Fatigue (50%) Anorexia and weight loss Fever with or without an identifiable infection (10%)
APLASTIC AND HYPOPLASTIC ANEMIAS Waggas Elaas. APLASTIC ANEMIA Aplastic anemia is a severe, life threatening syndrome in which production of erythrocytes,
Diseases Of The Blood Prof.Ahmed Mohy. Red blood cell Disorder Anemia Reduction in RBCS &/or haemoglobin/unit volume of blood with low or normal blood.
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives chronic myeloid leukaemia (CML) Haematopoietic malignancies Polycythemia vera (PV) Idiopathic myelofibrosis.
The Chronic Lymphoid Leukaemias
Anemia of Chronic Disease
Associate professor of Internal Medicine
Acute Leukemia Kristine Krafts, M.D..
Malignancies of hematopoietic cells. Leukemia
Acute myeloid leukemia
LEUKEMIAS H.A. MWAKYOMA, MD.
CHRONIC LYMPHOCYTIC LEUKAEMIA CLL
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
MLAB Hematology Keri Brophy-Martinez
11 th lecture Chronic myeloid leukaemia By DR Fatehia Awny Faculty of Health Science Beirut Arab University
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
CHRONIC MYELOID LEUKEMIA (CML)
Associate professor of Internal Medicine
HS 4160 Critical Scientific Analysis
Case Study ….
Acute leukemia.
CASE STUDY Leukemia.
Hairy cell Leukemia Case study.
Myelodysplastic syndromes
Acute Leukemia Dr. Noha Noufal.
Chronic Leukemia Dr. Noha Noufal.
CHRONIC LEUKEMIA BY: DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST
MYELOID LEUKEMIAS Dr. B.V.Vydehi M.D PROFESSOR OF PATHOLOGY
Presentation transcript:

Chronic leukemias CML CLL MDS

Chronic myeloid leuk. (CML) Comprises less than 20% of all leuk. & is seen most frequently in middle age .In more than 95% of patients there is replacement of normal Bone Marrow (BM) by cells with abnormal chromosome (Philadelphia or Ph chromosome)

Philadelphia chromosome: is abnormal chromosome 22 due to translocation of part of long arm (q) of chromosome 22 to another chromosome ,usually 9 , with translocation of part of chromosome 9 including ABL oncogene to chromosome 22 It is aquired abnormality of haemopoietic stem cells that present in all dividing granulocytes, erythroid & megakaryocytic cells also in some B & minority of T lymphocytes .

Philadelphia chromosome:

Clinical features: This disease occure in either sex M:F= 1.4:1 Moat frequently between the age of 40-60y .It may occurs in children & neonates & very old There is no predisposing factor but the incidence was increased in Japan after exposure to atomic bomb. 1-Symptoms of hypermetabolism e.g. weight loss, lassitude, anorexia or night sweat. 2- Splenomegaly is nearly always present & is frequently massive.

Clinical features 3- Features of anemia 4- Bruising, epistaxis, menorrhagia due to abnormal platelet function. 5- Gout or renal impairment due to hypercalcaemia from excessive purine breakdown 6- Rare symptoms include visual disturbances & priapism.

Lab. Findings: 1- Leucocytosis: is usually >50×109/L & some times >500×109/L . A complete spectrum of myeloid cells is seen in peripheral blood, the level of neutrophils & myelocytes exceed those of blast & promyelocytes 2- Ph chromosome on cytogenic analysis of blood or BM 3- BM is hyper cellular with granulopoietic predominance.

Lab. Findings: 4- Neutrophil alkaline phosphatase score is low 5- Increased circulating basophiles 6- Normochromic normocytic anemia 7- Platelets count may be increased, normal or decreased 8- Serum B12 & B12 binding capacity increased 9- Serum uric acid increased

Chronic lymphocytic leuk.(CLL) Account for 25% or more of leuk. seen in clinical practice & occurs chiefly in the elderly. The accumulation of large numbers of lymphocytes to 50-100 times the normal lymphoid mass in the blood, BM, spleen, lymph nodes & liver. The cells are monoclonal population of B- lymphocytes. T- cell chronic leuk. is uncommon.

Classification of chronic lymphoid leuk B-cell CLL 1-B-CLL 2-B-PLL 3-HCL 4-PCL T-cell CLL 1-T-CLL 2-T-PLL 3-Adult T- cell leuk./lymphoma.

Clinical features: 1- The disease occurs in older subjects & is rare before 40 y The M: F= 2:1 2- Symmetrical enlargement of superficial lymph nodes, the nodes are usually discrete & non tender. 3-Features of anemia may be present 4- Splenomegaly &hepatomegaly are usual in late stages 5- Bacterial or fungal infections are common in late stages

Clinical features 6- Patient with thrombocytopenia may show bruising or purpura. 7- Excessive reaction to vaccination & insect bite may occur 8- Skin infiltration is present in small number of patients 9-Tonsillar enlargement may be a feature 10- Many cases are diagnosed when routine blood test is performed (accidentally)

Lab. Findings 1- lymphocytosis : the absolute lymphocyte count is>5×109/L & may be up to 300 or more . between 70-99% of white cells in blood film appear as small lymphocytes .Smudged or smear cells are also present.

2- Normochromic ,normocytic anemia is present in late stages due to: BM infiltration Hypersplenism Autoimmune hemolytic anemia

Lab. Findings 3- Thrombocytopenia occurs in many patients 4- BM aspirate shows lymphocytic replacement of normal marrow elements. Lymphocytes comprise 25-95% of all cells 5-reduced concentration of S.Ig & this becomes more marked with advanced disease. 6-Trisomy12 or t (11:14) are the most frequent chromosome findings

Course & prognosis. CLL divided into 5 stages according to Rai classification Low levels of platelets Anemia Enlarged spleen or liver Swollen lymph nodes High levels of lymphocytes Ray Stage No Yes I Yes or no II III IV

These stages correlate with different prognosis e.g. Rai 0 with mean survival of 12 y Rai 1 with mean survival of 8 y

The international working classification (Binet) Low levels of platelets Anemia Number of lymph node areas Binet stage no Less than 3 A 3 or more B Yes (or anemia) Yes (or low platelets) Any number C

Myelodysplastic syndromes (MDS) A large group of acquired neoplastic disorders of BM , most common in elderly & characterized by increased BM failure with quantitative & qualitative abnormalities of all 3 myeloid cell lines (red cells, granulocyte/monocyte &platelets ) due to defect of stem cells & ineffective haemopoiesis so that cytopenias often accompany a marrow of normal or increased cellularity. In most cases , the disease arises de novo , but in significant proportion chemotherapy &/or radiotherapy has previously been given for another hematological diseases.

Classification BM Peripheral blood 50 Blast<5% Blast <1% Survival (Ms) BM Peripheral blood 50 Blast<5% Blast <1% Refractory anemia(RA) Blast<5% ring sidroblasts >15% of total erythroblasts Refractory anemia with ring sidroblast (RARS) 11 Blast 5-20 % RA with excess blast(RAEB) 5 Blast 20-30% or auer rods Blast>5% RAEB with transformation (RAEB-t) Any of the above with promonocytes Any of the above with >1×10/L monocytes Chronic myelomonocytic leuc.(CMML)

Clinical features 50% of patients are >70 years, &<25% are <50 y old. -Male are more commonly affected. - The evolution is often slow & the disease may be found by chance -The symptoms if present are that of anemia, infections or of easy bruising or bleeding.

Clinical features -In some patients, transfusion dependant an. dominates the course. While in others recurrent infection or spontaneous bruising or bleeding is the major clinical problem. -Neutophils, monocytes & platelets are often functionally impaired lead to spontaneous infections, bruising or bleeding regardless the severity of cytopenias. -The spleen is not usually enlarged except in CMML in which gum hypertrophy & lymphadenopathy may occur.

Lab. Findings: 1- peripheral blood: pancytopenia is frequent finding The red cells are usually macrocytic or dimorphic but occationally hypochromic , normoblast may be present., the reticulocyte count is low . Granulocytes are often reduced &may show lack of granulation .Their chemotactic,phagocytic &adhesive function are impaired. The pelger abnormality (single or bilobed nucleus) is often present. In CMML, monocytes are>1×109/L in the blood & total WBC >100×109/L . The platelets may be unduly large or small & are usually decreased in number but in 10% of cases are elevated. In poor prognosis cases myeloblasts are present in blood

2-BM: the cellularity is usually increased, ring sidroblast may occur in all 5 FAB types, but by definition they are>15% in RARS Multinucleated normoblasts & other dyserythropoietic features are seen The granulocyte precursors show defective primary & secondary granulation Megakaryocytes are abnormal with micto , small binuclear or polynuclear forms BM biopsy shows fibrosis in 10% of cases.

3-Chromosomal & oncogene abnormalities: Cytogenic abnormalities are more frequent in secondary than primary MDS & most commonly constitute partial or total loss of chromosome 5,7,Y or trisomy 8 RAS oncogene (N-RAS) mutation occur in 20% of cases FMS mutation occur in 15% of cases